APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Published on 28 Nov 2024 on Zacks · via Yahoo Finance

Applied Therapeutics stock plummets 77% after the FDA issues a CRL for the company's NDA seeking...

Read the rest of the article

Start tracking your investments with Statfolio

, opens new tab said on Monday it received a warning letter limited to a trial studying its genet...

Reuters 2 Dec 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 2 Dec 2024

MicroStrategy, Nu Holdings Stir Friday's Market Cap Stock Movers

Investing.com 29 Nov 2024

Applied Therapeutics stock plummets 77% after the FDA issues a CRL for the company's NDA seeking...

Zacks · via Yahoo Finance 28 Nov 2024

Oracle, Salesforce dip among Thursday's market cap stock movers

Investing.com 28 Nov 2024

, opens new tab said on Wednesday that the U.S. FDA declined to approve its drug to treat...

Reuters 27 Nov 2024

Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder...

Benzinga · via Yahoo Finance 19 Sep 2024

Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, A...

Benzinga · via Yahoo Finance 19 Jul 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Revenue: Reported at $190K for Q1 2024, significantly below estimates of $3.33M.Net Loss: Increas...

GuruFocus.com via Yahoo Finance 10 May 2024